Sunday, December 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Price Targets for Universal Health Services NYSE UHS

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

Analyst Sarah James from Cantor Fitzgerald maintains her Underweight rating on Universal Health Services (NYSE: UHS) but has increased the price target to $156 from $148. As of February 29, 2024, the average price target for UHS stands at $173.83, with a high forecast of $190.00 and a low forecast of $161.00, suggesting a 5.79% change.

Other analysts have provided their own price targets, including Credit Suisse at $163.00, Barclays at $142.00, and Deutsche Bank at $155 (up from $145). The varying opinions from analysts indicate a range of perspectives on Universal Health Services’ stock performance and price targets.

Universal Health Services, Inc. (UHS) Stock Soars on February 29, 2024: Positive Performance and Strong Opening

On February 29, 2024, Universal Health Services, Inc. (UHS) saw a positive performance in the stock market. According to data from CNN Money, UHS was trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well over the past year and is currently in an upward trend.

The price of UHS shares increased by $3.68 since the market last closed, representing a 2.28% rise. The stock opened at $163.13, which was $1.40 higher than its previous close. This strong opening suggests that investors were optimistic about the company’s prospects on that day.

Universal Health Services, Inc. (UHS) Reports Strong Financial Performance for 2023: Revenue and EPS Growth Signals Stability and Potential

On February 29, 2024, Universal Health Services, Inc. (UHS) reported its financial performance for the past year and the fourth quarter. According to data from CNN Money, UHS generated a total revenue of $14.28 billion over the past year, which represents a 6.59% increase compared to the previous year. In the fourth quarter alone, the company brought in $3.70 billion in revenue, showing a 3.95% increase from the previous quarter.

In terms of net income, UHS reported a total of $717.79 million for the year, up 6.36% from the previous year. However, in the fourth quarter, the net income remained flat at $216.38 million. Despite the quarterly stagnation, the annual increase in net income is a positive sign for the company’s financial health.

Earnings per share (EPS) also saw significant growth for UHS. The company reported an EPS of $10.23 for the year, marking an 11.92% increase from the previous year. In the fourth quarter, the EPS rose to $3.16, showing a substantial 31.79% increase from the previous quarter.

Overall, UHS’s stock performance on February 29, 2024, reflects a strong financial performance over the past year, with steady revenue growth and increasing earnings per share. Investors may view these positive indicators as a sign of the company’s stability and potential for future growth.

Tags: UHS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Renewable energy

Imperial Oil AMEX IMO Stock Analysis Impressive Performance and Growth Potential

Food Retailers Stock Bull Market

Etsy Unusual Options Activity Analysis Potential Market Shift on the Horizon

Analyst Sentiments Towards Mirum Pharmaceuticals A Mixed Bag

Recommended

JD.com Stock

Pivotal Week Ahead for JD.com as Major European Acquisition and EV Launch Converge

2 months ago
Snowflake Stock

Snowflake Faces Investor Confidence Test After Executive’s Rogue Forecast

2 months ago
Fiserv Stock

Fiserv’s Strategic Expansion Meets Legal Scrutiny

3 months ago
Does_Walmart_Take_Google_Pay

Does Walmart Take Google Pay? Exploring Walmart’s Exclusive Payment Solution

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Bitcoin Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

Strategy Inc. Faces a Critical Index Classification Decision

DeFi Technologies Broadens Global Reach with New Listings and Products

Barrick Gold Secures Key Resolution in Mali, Paving Way for Mine Restart

Analyst Upgrade Sends Red Cat Shares Soaring

A Billion-Dollar Vote of Confidence for Standard Lithium

Trending

Tesla Stock
Automotive & E-Mobility

Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push

by Dieter Jaworski
December 21, 2025
0

Tesla shares are trading near their 52-week high as the company approaches a pivotal week, fueled by...

Wolfspeed Stock

Wolfspeed Secures Financial and Strategic Milestones

December 21, 2025
Textron Stock

Textron Stock Approaches Annual Peak Amid Strategic Wins

December 21, 2025
Intellia Therapeutics Stock

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

December 21, 2025
Strategy Stock

Strategy Inc. Faces a Critical Index Classification Decision

December 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push
  • Wolfspeed Secures Financial and Strategic Milestones
  • Textron Stock Approaches Annual Peak Amid Strategic Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com